Release Date: 06/03/13 16:31 Summary: Appendix 3B Vesting of PSRs Options Price Sensitive: No Download Document 107.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%